Summit Technology seeks patent extension for excimer laser:
This article was originally published in Clinica
Executive Summary
Summit Technology is seeking 609 days' US patent extension for its Excimed UV200LA/SVS Apex Excimer Laser System which was approved in March this year for phototherapeutic keratectomy procedures. The US FDA has determined that the regulatory review period was 2,271 days, of which 1,156 occurred during the testing phase and 1,115 during the approval phase.